Florida Cancer Specialists & Research Institute, LLC (FCS) will host its 2024 Clinical Summit this week in Orlando, a three-day gathering attended by physicians, clinical practice providers and...

Elegoo, a rapidly developing brand in global smart manufacturing, is excited to announce its participation at Formnext 2024, one of the world's largest exhibitions for additive manufacturing. From...

From October 23rd to 24th, All Energy Australia 2024, the largest and most influential renewable energy exhibition in Australia, arrived as scheduled, covering fields such as solar energy, wind...

Data from a wide range of the Sun Pharma dermatology portfolio, including data on alopecia areata, psoriasis, acne and actinic keratosis products, will be highlighted during the meeting. MUMBAI, India

In first dedicated study of a selective IL-13 inhibitor in patients previously treated with dupilumab, the majority of patients had a history of inadequate response to dupilumab EBGLYSS also...

~33% ORR by RECIST 1.1: 1 CR + 8 PRs out of 27 evaluable heavily pre-treated (median 2-3 prior lines, ranging from 1-7) MTAP-deletion UC and NSCLC patients 9 of 9 responses have confirmed by...

GTCHAIR rocked the stage at the 2024 ORGATEC furniture exhibition in Cologne, Germany. Their booth, located at Hall 8.1 A060, showcased a cool range of office chairs that make sitting comfy and...

On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke...

A news report from chinadaily.com.cn： The 2024 World Internet Conference (WIC) Wuzhen Summit, which is set to take place from Nov 19 to 22 in Wuzhen, East China's Zhejiang province, will focus...

- Encouraging preliminary anti-tumor activity observed in heavily pre-treated population - - At ≥ 90 mg QD, 6 out of 11 (54.5%) patients with FGFR3+ mUC achieved a confirmed partial response...